Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (4): 391-400.doi: 10.19982/j.issn.1000-6621.20220525
• Original Articles • Previous Articles Next Articles
Duan Yuheng, Zhang Lanyue, Dong Jing, Shi Yuting, Jia Hongyan, Li Zihui, Xing Aiying, Du Boping, Sun Qi, Pan Liping, Zhu Chuanzhi(), Zhang Zongde()
Received:
2023-01-10
Online:
2023-04-10
Published:
2023-03-31
Contact:
Zhu Chuanzhi Email:chuanzhizhu@gmail.com; Zhang Zongde Email:zzd417@163.com
Supported by:
CLC Number:
Duan Yuheng, Zhang Lanyue, Dong Jing, Shi Yuting, Jia Hongyan, Li Zihui, Xing Aiying, Du Boping, Sun Qi, Pan Liping, Zhu Chuanzhi, Zhang Zongde. Effects of acetyltransferase fadA3 on acetylation of host protein and in vivo survival of Mycobacterium tuberculosis[J]. Chinese Journal of Antituberculosis, 2023, 45(4): 391-400. doi: 10.19982/j.issn.1000-6621.20220525
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20220525
GO地址 | 聚类名称 | 富集基因数 (个) | 构成比 (%) | Q值 |
---|---|---|---|---|
分子功能分析 | ||||
GO:0005125 | 细胞因子活性(cytokine activity) | 12 | 5 | <0.001 |
GO:0008009 | 趋化因子活性(chemokine activity) | 6 | 12 | <0.001 |
GO:0048248 | CXCR3趋化因子受体结合(CXCR3 chemokine receptor binding) | 3 | 60 | <0.001 |
GO:0045236 | CXCR趋化因子受体结合(CXCR chemokine receptor binding) | 3 | 20 | 0.004 |
GO:0008201 | 肝素结合(heparin binding) | 7 | 4 | 0.004 |
GO:0004992 | 血小板活化因子受体活性(platelet activating factor receptor activity) | 2 | 50 | 0.008 |
GO:0031727 | CCR2趋化因子受体结合(CCR2 chemokine receptor binding) | 2 | 33 | 0.017 |
GO:0048020 | CCR趋化因子受体结合(CCR chemokine receptor binding) | 3 | 10 | 0.020 |
生物进程分析 | ||||
GO:0060337 | Ⅰ型干扰素信号通路(type Ⅰ interferon signaling pathway) | 11 | 16 | <0.001 |
GO:0006955 | 免疫应答(immune response) | 18 | 5 | <0.001 |
GO:0002376 | 免疫系统进程(immune system process) | 20 | 4 | <0.001 |
GO:0045071 | 病毒基因组复制的负调控(negative regulation of viral genome replication) | 8 | 18 | <0.001 |
GO:0045087 | 先天免疫反应(innate immune response) | 18 | 4 | <0.001 |
GO:0070098 | 细胞因子介导信号通路(cytokine-mediated signaling pathway) | 8 | 11 | <0.001 |
GO:0006935 | 趋化作用(chemotaxis) | 10 | 6 | <0.001 |
GO:0006954 | 炎症应答(inflammatory response) | 13 | 3 | <0.001 |
GO:0009617 | 细菌反应(response to bacterium) | 7 | 6 | <0.001 |
GO:0030593 | 中性粒细胞趋化性(neutrophil chemotaxis) | 6 | 7 | <0.001 |
细胞组分分析 | ||||
GO:0005576 | 胞外区域(extracellular region) | 29 | 1 | 0.001 |
GO:0005634 | 细胞外隙(extracellular space) | 22 | 1 | 0.002 |
通路编码 | 通路名称 | 富集基因数 (个) | 构成比 (%) | Q值 |
---|---|---|---|---|
hsa04061 | 病毒蛋白与细胞因子和细胞因子受体的相互作用(viral protein interaction with cytokine and cytokine receptor) | 10 | 10 | <0.001 |
hsa04060 | 细胞因子-细胞因子受体相互作用(cytokine-cytokine receptor interaction) | 15 | 5 | <0.001 |
hsa05160 | 丙型病毒性肝炎(hepatitis C) | 8 | 5 | 0.001 |
hsa05164 | 甲型流感病毒(influenza A) | 8 | 5 | 0.002 |
hsa04062 | 趋化因子信号通路(chemokine signaling pathway) | 8 | 4 | 0.003 |
hsa04620 | Toll样受体信号通路(Toll-like receptor signaling pathway) | 5 | 5 | 0.027 |
hsa04623 | 胞质DNA传感途径(cytosolic DNA-sensing pathway) | 4 | 6 | 0.028 |
hsa04622 | RIG-Ⅰ样受体信号通路(RIG-Ⅰ-like receptor signaling pathway) | 4 | 6 | 0.036 |
hsa04621 | NOD样受体信号通路(NOD-like receptor signaling pathway) | 6 | 3 | 0.042 |
[1] |
Kilinç G, Saris A, Ottenhoff THM, et al. Host-directed therapy to combat mycobacterial infections. Immunol Rev, 2021, 301(1):62-83. doi:10.1111/imr.12951.
doi: 10.1111/imr.12951 pmid: 33565103 |
[2] |
Budzik JM, Swaney DL, Jimenez-Morales D, et al. Dynamic post-translational modification profiling of Mycobacterium tuberculosis-infected primary macrophages. ELife, 2020, 9:e51461. doi:10.7554/eLife.51461.
doi: 10.7554/eLife.51461 URL |
[3] |
Chandran A, Antony C, Jose L, et al. Mycobacterium tuberculosis Infection Induces HDAC1-Mediated Suppression of IL-12B Gene Expression in Macrophages. Front Cell Infect Microbiol, 2015, 5: 90. doi:10.3389/fcimb.2015.00090.
doi: 10.3389/fcimb.2015.00090 |
[4] |
Wang Y, Curry HM, Zwilling BS, et al. Mycobacteria inhibition of IFN-gamma induced HLA-DR gene expression by up-regulating histone deacetylation at the promoter region in human THP-1 monocytic cells. J Immunol, 2005, 174(9): 5687-5694. doi:10.4049/jimmunol.174.9.5687.
doi: 10.4049/jimmunol.174.9.5687 pmid: 15843570 |
[5] |
Zhu C, Cai Y, Zhu J, et al. Histone deacetylase inhibitors impair the host immune response against Mycobacterium tuberculosis infection. Tuberculosis (Edinb), 2019, 118: 101861. doi:10.1016/j.tube.2019.101861.
doi: 10.1016/j.tube.2019.101861 URL |
[6] |
Duan L, Yi M, Chen J, et al. Mycobacterium tuberculosis EIS gene inhibits macrophage autophagy through up-regulation of IL-10 by increasing the acetylation of histone H3. Biochem Biophys Res Commun, 2016, 473(4): 1229-1234. doi:10.1016/j.bbrc.2016.04.045.
doi: 10.1016/j.bbrc.2016.04.045 URL |
[7] |
Jose L, Ramachandran R, Bhagavat R, et al. Hypothetical protein Rv3423.1 of Mycobacterium tuberculosis is a histone acetyltransferase. FEBS J, 2016, 283(2): 265-281. doi:10.1111/febs.13566.
doi: 10.1111/febs.13566 URL |
[8] |
Målen H, Berven FS, Fladmark KE, et al. Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics, 2007, 7(10): 1702-1718. doi:10.1002/pmic.200600853.
doi: 10.1002/pmic.200600853 pmid: 17443846 |
[9] |
Yan MY, Li SS, Ding XY, et al. A CRISPR-Assisted Nonhomologous End-Joining Strategy for Efficient Genome Editing in Mycobacterium tuberculosis. MBio, 2020, 11(1): e02364-19. doi:10.1128/mBio.02364-19.
doi: 10.1128/mBio.02364-19 |
[10] |
朱国峰, 刘晓清. 结核病比较免疫学时代的机遇和挑战. 结核与肺部疾病杂志, 2020, 1(3): 195-212. doi:10.3969/j.issn.2096-8493.2020.03.002.
doi: 10.3969/j.issn.2096-8493.2020.03.002 |
[11] |
Zhang LY, Wang CL, Yan MY, et al. Toxin-Antitoxin Systems Alter Adaptation of Mycobacterium smegmatis to Environmental Stress. Microbiol Spectr, 2022, 10(6):e0281522. doi:10.1128/spectrum.02815-22.
doi: 10.1128/spectrum.02815-22 |
[12] |
Gu S, Chen J, Dobos KM, et al. Comprehensive proteomic profiling of the membrane constituents of a Mycobacterium tuberculosis strain. Mol Cell Proteomics, 2003, 2(12): 1284-1296. doi:10.1074/mcp.M300060-MCP200.
doi: 10.1074/mcp.M300060-MCP200 URL |
[13] |
Kim SC, Sprung R, Chen Y, et al. Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. Mol Cell, 2006, 23(4): 607-618. doi:10.1016/j.molcel.2006.06.026.
doi: 10.1016/j.molcel.2006.06.026 pmid: 16916647 |
[14] |
Arun KB, Madhavan A, Abraham B, et al. Acetylation of Isoniazid Is a Novel Mechanism of Isoniazid Resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2020, 65(1): e00456-20. doi:10.1128/AAC.00456-20.
doi: 10.1128/AAC.00456-20 |
[15] |
Reygaert WC. An overview of the antimicrobial resistance mechanisms of bacteria. AIMS Microbiol, 2018, 4(3): 482-501. doi:10.3934/microbiol.2018.3.482.
doi: 10.3934/microbiol.2018.3.482 pmid: 31294229 |
[16] |
Schwarz S, Kehrenberg C, Doublet B, et al. Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol Rev, 2004, 28(5): 519-542. doi:10.1016/j.femsre.2004.04.001.
doi: 10.1016/j.femsre.2004.04.001 pmid: 15539072 |
[17] |
Anand C, Santoshi M, Singh PR, et al. Rv0802c is an acyltransferase that succinylates and acetylates Mycobacterium tuberculosis nucleoid-associated protein HU. Microbiology (Reading), 2021, 167(7):001058. doi:10.1099/mic.0.001058.
doi: 10.1099/mic.0.001058 |
[18] |
Yang H, Sha W, Liu Z, et al. Lysine acetylation of DosR regulates the hypoxia response of Mycobacterium tuberculosis. Emerg Microbes Infect, 2018, 7(1): 34. doi:10.1038/s41426-018-0032-2.
doi: 10.1038/s41426-018-0032-2 |
[19] |
Sharma A, Kumar A, Rashid M, et al. A Phagosomally Expressed Gene, rv0428c, of Mycobacterium tuberculosis Demonstrates Acetyl Transferase Activity and Plays a Protective Role Under Stress Conditions. Protein J, 2022, 41(2): 260-273. doi:10.1007/s10930-022-10044-x.
doi: 10.1007/s10930-022-10044-x |
[20] |
Yang H, Wang F, Guo X, et al. Interception of host fatty acid metabolism by mycobacteria under hypoxia to suppress anti-TB immunity. Cell Discov, 2021, 7(1): 90. doi:10.1038/s41421-021-00301-1.
doi: 10.1038/s41421-021-00301-1 pmid: 34608123 |
[21] |
Rosenkrands I, King A, Weldingh K, et al. Towards the proteome of Mycobacterium tuberculosis. Electrophoresis, 2000, 21(17): 3740-3756. doi:10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.0.CO;2-3.
doi: 10.1002/1522-2683(200011)21:17<3740::AID-ELPS3740>3.0.CO;2-3 pmid: 11271494 |
[22] |
Schaefer CM, Lu R, Nesbitt NM, et al. FadA5 a thiolase from Mycobacterium tuberculosis: a steroid-binding pocket reveals the potential for drug development against tuberculosis. Structure, 2015, 23(1): 21-33. doi:10.1016/j.str.2014.10.010.
doi: 10.1016/j.str.2014.10.010 URL |
[23] |
Jaiswal AK, Husaini SHA, Kumar A, et al. Designing novel inhibitors against Mycobacterium tuberculosis FadA 5 (acetyl-CoA acetyltransferase) by virtual screening of known anti-tuberculosis (bioactive) compounds. Bioinformation, 2018, 14(6): 327-336. doi:10.6026/97320630014327.
doi: 10.6026/97320630014327 pmid: 30237678 |
[24] |
Sandhu P, Kumari M, Naini K, et al. Genome scale identification, structural analysis, and classification of periplasmic binding proteins from Mycobacterium tuberculosis. Curr Genet, 2017, 63(3): 553-576. doi:10.1007/s00294-016-0664-5.
doi: 10.1007/s00294-016-0664-5 URL |
[25] |
De Souza GA, Leversen NA, Målen H, et al. Bacterial proteins with cleaved or uncleaved signal peptides of the general secretory pathway. J Proteomics, 2011, 75(2): 502-510. doi:10.1016/j.jprot.2011.08.016.
doi: 10.1016/j.jprot.2011.08.016 pmid: 21920479 |
[26] |
Chai Q, Wang L, Liu CH, et al. New insights into the evasion of host innate immunity by Mycobacterium tuberculosis. Cell Mol Immunol, 2020, 17(9): 901-913. doi:10.1038/s41423-020-0502-z.
doi: 10.1038/s41423-020-0502-z |
[27] |
Novita BD, Tjahjono Y, Wijaya S, et al. Characterization of chemokine and cytokine expression pattern in tuberculous lymphadenitis patient. Front Immunol, 2022, 13: 983269. doi:10.3389/fimmu.2022.983269.
doi: 10.3389/fimmu.2022.983269 URL |
[28] |
Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol Rev, 2011, 240(1): 92-104. doi:10.1111/j.1600-065X.2010.00995.x.
doi: 10.1111/j.1600-065X.2010.00995.x pmid: 21349088 |
[1] | Zhao Aihua, Du Weixin, Wang Guozhi, Xu Miao. Discussion on the nomenclature of recombinant Mycobacterium tuberculosis allergen skin test [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 333-335. |
[2] | Zhang Pei, Zhao Ahui, Gao Min, Zhen Xinan, Yao Yuxia, Jiang Jianguo, Sun Jianwei, Sun Dingyong. Epidemiological characteristics of MTB/HIV co-infection in Henan from 2016 to 2021 [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 377-382. |
[3] | Zhu Yumei, Xia Zihan, Li Jinli, He Huishan, Wang Feng. Application value of multicolor melting curve analysis in detection of pre-extensive drug-resistant pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 406-411. |
[4] | Wang Wenjing, Sun Hong, Sun Zhaogang. Progress of innate immune mechanism activated by Mycobacterium tuberculosis DNA-mediated pattern recognition receptors [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 426-433. |
[5] | Zou Yuanwu, Li Jing, Wang Biao, Wang Zhuo, Qu Shaoyi, Yuan Zhimin, Wu Qianhong. The diagnostic value of simultaneous amplification and testing for Mycobacterium tuberculosis technique on alveolar lavage fluid for diagnosing pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(4): 434-436. |
[6] | Xia Hui, Wang Ruibai, Zhao Yanlin. Differential diagnosis between latent tuberculosis infection and active tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(3): 253-259. |
[7] | Shi Dawei, Wang Wei, Yang Xiao, Yu Li, Huang Jiawei, Zhang Chuntao, Xu Sihong. Establishment of national reference panel for Mycobacterium tuberculosis antibody detection kits [J]. Chinese Journal of Antituberculosis, 2023, 45(3): 285-291. |
[8] | Guo Tonglei, Cao Xuefang, Gao Lei. Interpretation of the Operation specification of Mycobacterium tuberculosis recombinant protein skin test [J]. Chinese Journal of Antituberculosis, 2023, 45(2): 130-133. |
[9] | Dai Zhenwei, Zhang Haoran, Jing Shu, Xiao Weijun, Wang Hao, Huang Yiman, Chen Xu, Fu Jiaqi, Wu Yijin, Gao Lei, Su Xiaoyou. Effect of mindfulness level on mental health of middle-aged and elderly people with type 2 diabetes mellitus comorbidity latent tuberculosis infection in rural areas [J]. Chinese Journal of Antituberculosis, 2023, 45(2): 188-194. |
[10] | Zhou Yan, Zhou Meng, Peng Jun, Duan Qionghong, Chen Jun, Zhou Meilan, Zhang Yunxia, Liang Jun. Analysis on transmission of multidrug-resistant pulmonary tuberculosis in family [J]. Chinese Journal of Antituberculosis, 2023, 45(2): 195-199. |
[11] | Qu Yunmo, Ding Xinyuan, Yan Meiyi, Guo Xiaopeng, Sun Yicheng. Development and application of CRISPR assisted genome editing technology in Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2023, 45(2): 208-214. |
[12] | Wang Zeming, Shen Adong. Interpretation of the standard of Detection and preventive treatment of latent tuberculosis infection in children [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 13-17. |
[13] | Yu Meiling, Zhang Chenchen, Wei Wenjing, Zhao Yuchuan, Zhuo Wenji, Zheng Lei. Study on high-concentration p-aminosalicylic acid resistant Mycobacterium tuberculosis induced in vitro and the mutation sites [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 60-66. |
[14] | Sheng Yunfeng, Qiu Meihua, Chen Yuanyuan, Sun Lifang, Zhen Libo. Research on mechanisms of dendritic cell miR-17 regulating naive CD4+T lymphocytes unevenly differentiating to Treg/Th17 [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 67-72. |
[15] | Wei Shuzhen, Zhao Yong, Lin Jian, Lin Shufang, Dai Zhisong. Analysis of genotype characteristics and drug resistance of Mycobacterium tuberculosis isolates in Fujian Province from 2017 to 2019 [J]. Chinese Journal of Antituberculosis, 2023, 45(1): 73-78. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||